Hospitalization rates for complications due to systemic therapy in the United States
Anshul Saxena(Florida International University), Rupesh Kotecha(Baptist Hospital of Miami), Michael D. Chuong(Baptist Hospital of Miami), Muni Rubens(Florida International University), Yazmín Odia(Baptist Hospital of Miami), Minesh P. Mehta(Columbia University), Venkataraghavan Ramamoorthy(Baptist Health South Florida), Subrina Sundil(Southeastern Health), Matthew D. Hall(Baptist Hospital of Miami), Peter McGranaghan(Deutsches Herzzentrum der Charité), Raees Tonse(Miami Heart Research Institute), Emir Veledar(University of Miami)
Cited by 24
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden
|Circulation|2008|1.6k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
|Journal of Clinical Oncology|2012|1.2k